Personal KinetiGraph® (PKG®) System

DEVICE2 trials

Sponsors

Global Kinetics Corporation

Conditions

Movement DisordersParkinson Disease

Unknown Phase

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG

WithdrawnNCT04381065

Global Kinetics CorporationParkinson Disease

Start: 2020-06-30End: 2026-04-30Updated: 2021-02-01

Personal KinetiGraph® Clinical Validation Study

CompletedNCT05251701

Global Kinetics CorporationMovement Disorders, Parkinson Disease

Start: 2022-12-09End: 2025-09-03Updated: 2025-10-14